KYNTRA BIO, INC. (KYNB) › Total AssetsKYNTRA BIO, INC. (KYNB) — Total AssetsAnnual figures by fiscal year, from SEC filings.2014: $483.53M2015: $470.57M2016: $469.55M2017: $898.65M2018: $880.60M2019: $857.40M2020: $826.84M2021: $773.82M2022: $610.09M2023: $423.53M2024: $214.53M2025: $119.59M$119.59M2014Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$119.59M-44.3%2024$214.53M-49.3%2023$423.53M-30.6%2022$610.09M-21.2%2021$773.82M-6.4%2020$826.84M-3.6%2019$857.40M-2.6%2018$880.60M-2.0%2017$898.65M+91.4%2016$469.55M-0.2%2015$470.57M-2.7%2014$483.53M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share